Levocetirizine DiHCl

Company Description:
Kyung Dong Pharm. Co., Ltd. continues to pursue in the advancing the corporate goal of improving the quality of human life and health following the core values of sincere servitude, utmost diligence and innovative development. The Baran API plant has been constructed in 2014 and approved by KMFDS with KGMP certification in the following year of 2015. The plant is adequately equipped to manufacture high quality APIs with annual capacity between 10 to 15 tons of APIs. Domestically marketed APIs have generally have been approved with KMDF certification, with multiple APIs approved with Japanese PMDA JDMF and exported to Japan and China. Kyung Dong Pharm. believes in building and upholding the trust between the customer and the company as greatest value in providing the highest quality API products that meets to need of our customers.